E2F3 transcription factor: A promising biomarker in lung cancer.
about
Quantification of STAT3 and VEGF expression for molecular diagnosis of lymph node metastasis in breast cancer.The clinical value of miR-193a-3p in non-small cell lung cancer and its potential molecular mechanism explored in silico using RNA-sequencing and microarray data.Transcriptional E2F1/2/5/8 as potential targets and transcriptional E2F3/6/7 as new biomarkers for the prognosis of human lung carcinoma.HOXB9 promotes endometrial cancer progression by targeting E2F3.
P2860
E2F3 transcription factor: A promising biomarker in lung cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
E2F3 transcription factor: A promising biomarker in lung cancer.
@en
E2F3 transcription factor: A promising biomarker in lung cancer.
@nl
type
label
E2F3 transcription factor: A promising biomarker in lung cancer.
@en
E2F3 transcription factor: A promising biomarker in lung cancer.
@nl
prefLabel
E2F3 transcription factor: A promising biomarker in lung cancer.
@en
E2F3 transcription factor: A promising biomarker in lung cancer.
@nl
P2860
P356
P1433
P1476
E2F3 transcription factor: A promising biomarker in lung cancer.
@en
P2093
Hala Abdel Al Ahmed
P2860
P356
10.3233/CBM-160196
P577
2017-02-27T00:00:00Z